ADC Therapeutics S.A.
ADCTNYSEHealthcare● Active
$0.97
$-0.06(-6.22%)
Market Cap$122853787
P/E Ratio—
52W High$4.98
52W Low$0.9848
ADC Therapeutics S.A.（ADCT）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ADCT · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $81.36M | $70.84M | $69.56M | $209.91M | $33.92M |
| Cost of Revenue | $7.67M | $5.95M | $2.53M | $3.30M | $1.39M |
| Gross Profit | $73.68M | $64.89M | $67.03M | $206.61M | $32.52M |
| Gross Margin %(computed) | 90.57% | 91.60% | 96.36% | 98.43% | 95.89% |
| Operating Expenses | |||||
| R&D Expenses | $104.00M | $109.63M | $127.13M | $186.46M | $158.00M |
| G&A Expenses | $36.56M | $64.47M | $72.88M | $107.74M | $71.46M |
| Total Operating Expenses | $182.06M | $195.54M | $233.01M | $329.95M | $294.24M |
| Operating Income | ($108.38M) | ($130.65M) | ($165.99M) | ($123.34M) | ($261.72M) |
| Operating Margin %(computed) | -133.21% | -184.44% | -238.63% | -58.76% | -771.65% |
| Interest Income | $8.81M | $12.27M | $10.54M | $2.57M | $0.07M |
| Interest Expense | $51.63M | $50.21M | $46.33M | $36.73M | $18.34M |
| Income Before Tax | ($142.78M) | ($157.68M) | ($200.95M) | ($156.90M) | ($251.50M) |
| Income Tax Expense | ($0.16M) | $0.17M | $39.11M | $0.23M | ($21.48M) |
| Net Income | ($142.62M) | ($157.85M) | ($240.05M) | ($157.13M) | ($230.03M) |
| Net Margin %(computed) | -175.31% | -222.83% | -345.11% | -74.86% | -678.20% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.12 | $-1.62 | $-2.94 | $-1.99 | $-3.00 |
| Wtd Avg Shares | 127.07M | 97.16M | 81.71M | 78.15M | 76.75M |
| EBITDA | ($106.50M) | ($102.65M) | ($145.83M) | ($107.70M) | ($230.53M) |
| EBITDA Margin %(computed) | -130.91% | -144.91% | -209.65% | -51.31% | -679.70% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解ADC Therapeutics S.A.
关于ADC Therapeutics S.A.（ADCT）损益表
ADC Therapeutics S.A.（ADCT）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，ADCT实现营收$0.08B，毛利润$0.07B（毛利率90.57%），净利润($0.14B)（净利率-175.31%）。
常见问题
ADCT · 4 问ADC Therapeutics S.A.（ADCT）2025财年营收为$0.08B，同比up14.9%。
ADCT revenueADCT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08